NDC 81033-412-30 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-412
- Requested NDC
- 81033-412-30
- Package NDCs from labels
- 81033-412-15, 81033-412-51, 81033-412-50, 81033-412-30, 81033-412-32, 81033-412-34
- Manufacturer
- Kesin Pharma
- Effective date
- 2024-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - Kesin Pharma | Kesin Pharma | 2024-12-04 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-412-15 | Potassium Chloride | 15 mL in 1 CUP, UNIT-DOSE | SOLUTION | 15 | 5 | |
| 81033-412-30 | Potassium Chloride | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 5 | |
| 81033-412-32 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-34 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 | |
| 81033-412-50 | Potassium Chloride | 100 in 1 CASE | SOLUTION | 100 | 5 | |
| 81033-412-51 | Potassium Chloride | 50 in 1 CASE | SOLUTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-412-15 | ML - Milliliter | 81033-412 | bbfbf218-c6fa-4f1f-a0b0-fd6c48577135 | 1 | 2024-08-12 |
| 81033-412-30 | ML - Milliliter | 81033-412 | b5400981-8240-485c-9d9f-87593850377e | 1 | 2024-08-12 |
| 81033-412-32 | ML - Milliliter | 81033-412 | 1d5cbd7d-98e5-4435-a285-be3bbff8b14a | 1 | 2024-08-12 |
| 81033-412-34 | ML - Milliliter | 81033-412 | ee33d2e1-7700-4f90-a7b5-9808c406891d | 1 | 2024-09-09 |
| 81033-412-50 | ML - Milliliter | 81033-412 | 3ec55d88-9e5c-430c-a4e9-fd74b75400de | 1 | 2024-08-12 |
| 81033-412-51 | ML - Milliliter | 81033-412 | a4c9fc82-8b5d-4db7-8def-ac8c2c3d5a44 | 1 | 2024-08-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 5aa0adf8-7b84-4cb0-be31-5c3333a6cc44 | 2023-12-11 | Warnings, Adverse reactions | 660YQ98I10 |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | B22547B95K |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 5c4b0be5-625e-435f-9d2c-9d8fb407a8ea | 2023-12-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | d033c3b3-3ed6-4f23-a555-bae40cf0c48f | 2023-12-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| Renotox | TRITICUM AESTIVUM, ASPARAGUS OFFICINALIS, BERBERIS VULGARIS, ECHINACEA (ANGUSTIFOLIA), KALI MURIATICUM, PETROSELINUM SATIVUM, SABAL SERRULATA, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, UVA-URSI, BAROSMA (BETULINA), EUPATORIUM PURPUREUM, KIDNEY (SUIS), BRYONIA (ALBA), MERCURIUS CORROSIVUS, ALUMINUM METALLICUM, ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, ARSENICUM ALBUM, AURUM METALLICUM, BARYTA CARBONICA, BERYLLIUM METALLICUM, BISMUTHUM METALLICUM, BORON, BROMIUM, CADMIUM METALLICUM, CERIUM METALLICUM, | BioActive Nutritional, Inc. | b501f7bc-fa3a-494e-bf95-6779a3169a49 | 2023-11-17 | Warnings | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Sun Pharmaceutical Industries, Inc. | 0a1f2f64-3b0b-5e5c-e063-6294a90a7185 | 2023-11-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86093c75-6de0-bb16-e053-2991aa0ab6ef | 2023-11-13 | 660YQ98I10 | |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 86090ebb-0fb2-2c9c-e053-2a91aa0a0561 | 2023-11-13 | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.